WEC
AXSM icon

Winslow Evans & Crocker’s Axsome Therapeutics AXSM Stock Holding History

Winslow Evans & Crocker’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$27K Hold
330
– – 0.01% 720
2020
Q3 		$24K Hold
330
– – 0.01% 587
2020
Q2 		$27K Hold
330
– – 0.01% 556
2020
Q1 		$20K Hold
330
– – 0.01% 570
2019
Q4 		$36K Hold
330
– – 0.01% 557
2019
Q3 		$8K Hold
330
– – ﹤0.01% 842
2019
Q2 		$10K Hold
330
– – ﹤0.01% 808
2019
Q1 		$6K Buy
+330
New +$3.06K ﹤0.01% 915

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Winslow Evans & Crocker's AXSM Position: Q4 2020 in Review

Winslow Evans & Crocker held its Axsome Therapeutics (AXSM) position steady in Q4 2020 at 330 shares worth $27K. The position accounts for 0.01% of the portfolio, ranked #720.

Winslow Evans & Crocker first reported a position in AXSM in Q1 2019 and has held it in 8 quarters since. The position peaked at $36K in Q4 2019. 179 funds tracked by Wall St. Rank hold AXSM as of Q4 2020.

  • Winslow Evans & Crocker held 330 shares of Axsome Therapeutics worth $27K as of Q4 2020.
  • Winslow Evans & Crocker left its Axsome Therapeutics share count unchanged in Q4 2020.
  • Axsome Therapeutics made up 0.01% of Winslow Evans & Crocker's portfolio in Q4 2020, its #720 holding.
  • Winslow Evans & Crocker first reported a position in Axsome Therapeutics in Q1 2019 and has held it in 8 quarters since.
  • Winslow Evans & Crocker's Axsome Therapeutics position peaked at $36K in Q4 2019.
  • 179 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.